Results 271 to 280 of about 14,301,803 (394)

Placebo Effect of Caffeine on Physiological Parameters and Physical Performance. [PDF]

Nutrients
Ortiz-Sánchez D, Bravo-Sánchez A, Ramírez-delaCruz M, Abián P, Abián-Vicén J.   +4 more
europepmc   +1 more source

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi, Ji Yun Kim, Lisa Seitz, Lixia Jin, Paul G. Foster, Kai H. Liao, Tzuling Cheng, Elaine Paterson, Maria Velinova, Nicole Rivera Rosario, Reza Khosravan, Balaji Agoram   +11 more
wiley   +1 more source

When does the placebo effect have an impact on network meta-analysis results? [PDF]

BMJ Evid Based Med
Nikolakopoulou A, Chaimani A, Furukawa TA, Papakonstantinou T, Rücker G, Schwarzer G.   +5 more
europepmc   +1 more source

Placebo Effect of Caffeine on Substrate Oxidation during Exercise. [PDF]

Nutrients, 2021
Gutiérrez-Hellín J, Ruiz-Moreno C, Aguilar-Navarro M, Muñoz A, Varillas-Delgado D, Amaro-Gahete FJ, Roberts JD, Del Coso J.   +7 more
europepmc   +1 more source

Mechanisms of the placebo effect in pain and psychiatric disorders

The Pharmacogenomics Journal, 2016
RD Holmes, AK Tiwari, JL Kennedy
semanticscholar   +1 more source

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour

British Journal of Clinical Pharmacology, EarlyView.
Aims Trial run‐in phases are sometimes used to select adherent participants as a strategy to enrich trials, but the methods employed lack clear regulatory guidance and there are concerns about the transparency of reporting. This review aims to characterize the methods used for adherence measurement and public reporting of run‐in studies.
Non Davies, Bernard Vrijens, Daniel F. B. Wright, Dyfrig A. Hughes   +3 more
wiley   +1 more source

Placebo Effect of Sham Spine Procedures in Chronic Low Back Pain: A Systematic Review. [PDF]

J Pain Res, 2021
Jamjoom AM, Saeedi RJ, Jamjoom AB.
europepmc   +1 more source

Is the perceived placebo effect comparable between adults and children? A meta-regression analysis

Pediatric Research, 2017
P. Janiaud, C. Cornu, A. Lajoinie, A. Djemli, M. Cucherat, B. Kassai   +5 more
semanticscholar   +1 more source

Reply

Arthritis &Rheumatology, EarlyView.
Spencer I. Danto, Elena Peeva
wiley   +1 more source

Mild psoriasis as a suitable model for proof‐of‐mechanism in a phase 1B setting: Results from a double‐blind placebo‐controlled trial with guselkumab

British Journal of Clinical Pharmacology, EarlyView.
Aims Early clinical development of novel psoriasis therapies is hampered by a decreasing number of moderate‐to‐severe psoriasis patients eligible for participation in trials since efficacious treatments, such as biologics, have become widely available.
Jannik Rousel, Menthe E. Bergmans, Lisa J. Bruijnincx, Sissi Lin, Tessa Niemeyer‐van der Kolk, Roman Bohoslavsky, Yalçin Yavuz, Naomi B. Klarenbeek, Joke A. Bouwstra, Robert Rissmann, Martijn B. A. van Doorn, the Next‐Generation ImmunoDermatology Consortium (NGID)   +11 more
wiley   +1 more source